C. Efrata, T. (2016) “R&D INTENSITY AND IPO UNDERPRICING: CASE STUDY ON PHARMACEUTICAL AND BIOTECH INDUSTRIES IN THE US”, Journal of Accounting and Investment, 9(1), pp. 1–21. Available at: https://journal.umy.ac.id/index.php/ai/article/view/1083 (Accessed: 1October2025).